OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of acetaldehyde dehydrogenase 2 in the pathogenesis of liver diseases
Yincui Wu, Yan Yao, Liang-song Tao, et al.
Cellular Signalling (2022) Vol. 102, pp. 110550-110550
Closed Access | Times Cited: 13

Showing 13 citing articles:

Acetaldehyde dehydrogenase 2 attenuates lipopolysaccharide -induced endothelial barrier damage by inhibiting mitochondrial fission in sepsis-associated encephalopathy
Shasha Wang, Zhongyi Liu, Rong Li, et al.
European Journal of Pharmacology (2025), pp. 177468-177468
Closed Access

Mitochondrial aldehyde dehydrogenase rescues against diabetic cardiomyopathy through GSK3β-mediated preservation of mitochondrial integrity and Parkin-mediated mitophagy
Yingmei Zhang, Rongjun Zou, Miyesaier Abudureyimu, et al.
Journal of Molecular Cell Biology (2023) Vol. 15, Iss. 9
Open Access | Times Cited: 8

SLC3A2, as an indirect target gene of ALDH2, exacerbates alcohol-associated liver cancer via the sphingolipid biosynthesis pathway
Xia Pu, Da-Hua Liu, Dan Wang, et al.
Free Radical Biology and Medicine (2023) Vol. 206, pp. 125-133
Open Access | Times Cited: 6

Role of Immunological Cells in Hepatocellular Carcinoma Disease and Associated Pathways
Ram Aasarey, Kajal Yadav, Brijendra Kumar Kashyap, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 12, pp. 1801-1816
Open Access | Times Cited: 5

Acetaldehyde Dehydrogenases in Liver Zonation and Liver Cancer
Brady Jin-Smith, Natacha Jn‐Simon, Sreenivasulu Basha, et al.
Gene Expression (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 4

ALDH2 deficiency exacerbates MCD-diet induced MASLD by modulating bile acid metabolism
Jun Luo, Zhongshan Lu, Zibiao Zhong, et al.
Free Radical Biology and Medicine (2023) Vol. 212, pp. 34-48
Closed Access | Times Cited: 4

Network pharmacology combined with metabolomics to reveal the anti-fibrotic mechanism of Polygoni Orientalis Fructus in CCl4-induced hepatic fibrosis rats
Lizhou Ma, Yu Chen, Rong Yue, et al.
Journal of Proteomics (2024) Vol. 304, pp. 105227-105227
Closed Access | Times Cited: 1

Aldehyde Dehydrogenase 2 (ALDH2): A novel sorafenib target in hepatocellular carcinoma unraveled by the proteome-wide cellular thermal shift assay
Inês C. Ferreira, Estefania Torrejón, Bernardo Abecasis, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 3, pp. 100154-100154
Open Access

ALDH2 attenuates radiation-induced lung injury by inhibiting ROS and epithelial-mesenchymal transition mediated by the TGF-β1/Smad pathway
E. Li, Jianliang Huang, Jingyi Huang, et al.
Pulmonary Pharmacology & Therapeutics (2024) Vol. 87, pp. 102334-102334
Open Access

Expression pattern and prognostic significance of aldehyde dehydrogenase 2 in lung adenocarcinoma as a potential predictor of immunotherapy efficacy
Silvia Baldari, Annalisa Antonini, Giuliana Di Rocco, et al.
Cancer Innovation (2024) Vol. 4, Iss. 1
Closed Access

The role of ALDHs in lipid peroxidation-related diseases
Y Wang, Shiyue Liu
International Journal of Biological Macromolecules (2024), pp. 138760-138760
Closed Access

Discovery of novel small-molecule aldehyde dehydrogenase 2 activators based on drug repurposing
Wei Tian, Xiangpei Sun, Xing Gao, et al.
Journal of Saudi Chemical Society (2023) Vol. 27, Iss. 6, pp. 101727-101727
Open Access | Times Cited: 1

Page 1

Scroll to top